Navigation Links
Oral use of ZYVOX (Linezolid) is better to Intravenous Vancomycin use for Skin Infections

McKinnon and his team have found out the benefits of oral ZYVOX for the treatment of skin infections and pneumonia caused by bacterial infections. They compared data from 80 health care clinics and compared it with the treatment // of Intravenous Vancomycin. The results show that oral tablets of Linezolid (ZYVOX), provides better treatment and significant savings of money spent to health clinics compared to vancomycin.

This study combining data from 80 health care clinics analyzed 1,048 adult patients treated with ZYVOX and compared it with 1,048 patients taking IV vancomycin between January 2002 and March 2004. Demographic, clinical and resource utilization data were collected for 12 months prior and during the 35 day observation period, including treatment duration.

During the follow-up period, 35 days after treatment, patients who received oral ZYVOX used significantly fewer health care resources in the six areas studied, including physician office visits (4.1 vs. 8.4 visits per patient; p<0.0001), emergency room visits (0.13 vs. 0.17; p=0.003), diagnostic claims (6.3 vs. 10.4; p<0.0001), other outpatient claims (8.9 vs. 18.4; p<0.0001), pharmacy claims (7.3 vs. 13.6; p<0.0001) and hospitalizations (0.19 vs. 0.23; p=0.024). The average total cost of care per patient was $4,630 (34 percent) less for ZYVOX patients compared with vancomycin patients ($8,922 vs. $13,552; p<0.0001).

EXPERTS VIEW OF ZYVOX:

“In short, patients were able to recover at home with less medical intervention than patients taking vancomycin,” said Yehuda Carmeli, MD, MPH, Beth Israel Deaconess Medical Center, Boston, Mass. and study investigator. “As the medical community strives to provide the best patient care while containing costs, these are important data for physicians to take under consideration.”

“This new information broadens our understanding of the benefits of oral linezolid,” said Peggy S. McKinnon, Pharm D, Clinical Pharmacist
'"/>




Page: 1 2

Related medicine news :

1. Homeopathic preparation better than placebo in perennial allergic
2. Patient’s perception of health status helps in better recover
3. For better mood and energy!! Work-up in short span
4. Antifever drug betters stroke outcome
5. Prevention is better than cure
6. A better way to measure cholesterol
7. Sponging Cattle betters spraying in eradicating Malaria
8. New therapy better at increasing bone density
9. Left handed have better episodic memory
10. Women recognise faces better
11. To get the better of
Post Your Comments:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ontrol Organization will be launching a month-long...hra Pradesh, Tamilnadu, Karnataka, Maharashtra, Ma...een HIV and TB. The campaign will be conducted thr...nt. It is pertinent to remember that the HIV virus...
...ring and Eugenics were developed by scientists wit...ry and remove all defective genes from the gene po...s are being made to order. Though it sounds absurd...tive baby?’- To some parents with disabilities lik...
...significantly cut down use of illicit drugs, but h...dangerous, say experts. // Dr. Grant Mitchell, chi...Center, in Mount Kisco, N.Y said, "This doesn't su...rescriptions for potentially legitimate uses for p...
...t that the people of India constitute more than on...e been underrepresented in studies related //to ge...on, complex genetic diseases associated with urban...ic proportions, making genetic cataloging and asso...
Other Medicine News:Health News:Can Defective Babies Be Made To Order? 2Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2
(Date:8/26/2008)... Coupled with Innovative Manufacturing - Has Poten...ic Preparedness, ROCKVILLE, Md., Aug. 26 /PRNewsw...nnounced today favorable results from the second s...s pandemic influenza virus-like,particle (VLP) vac...n an,adjuvant, induced robust neutralizing antibod...
(Date:8/25/2008)... Stem Cells Found in Menstrual Blood May Offer Lon...me-Pressed Women, OLDSMAR, Fla., Aug. 25 /PRNewsw... women would agree that there never seems to be en...pends on doing something just,for herself usually ...ers.,This reality has led many women in need of qu...
(Date:8/25/2008)...LLS, Mass., Aug. 25 /- Joseph F. Finn...Spherics, Inc. ("Spherics") for,the benefit of cre...tellectual property will be sold at a sealed bid a...ed release formulation of Levodopa-Carbidopa that,...on,s disease, with global,sales estimated at appro...
(Date:8/25/2008)...alif., Aug. 25 /- Anthera Pharmaceuti...any developing,anti-inflammatory drugs, today anno...nt Acute coronary events with Near-term Cardiovasc...gned to examine the impact of,varespladib when adm...Coronary Syndrome (ACS) event., The FRANCIS trial...
Breaking Medicine Technology:Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Mylan Announces Appointment of M Fabiana Lacerca as Senior Vice President and Chief Compliance Officer 1305 1Mylan Announces Appointment of M Fabiana Lacerca as Senior Vice President and Chief Compliance Officer 1305 2Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 1Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 2Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 3Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 4System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 1System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 2Common Foot Myths Trip Us Up 1298 1Common Foot Myths Trip Us Up 1298 2
... June 14, 2007) - Ambrilia,Biopharma Inc. (TSX:AMB...all molecules and peptides to treat infectious dis...ial Meeting today, during,which the data reported ...ibitors and recent developments were highlighted. ... Board, Mr. Frederic,Porte, and a progress report ...
...ewswire/ -- Results of the,Option (TOcilizumab Piv...trial, the first multinational Phase III study out...ctemra (either 4mg/kg,or 8mg/kg) plus methotrexate...mprovement in the signs and symptoms of moderate t...ients treated with,placebo and methotrexate, a cur...
Other Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
Corneal Trephine Punch - Stainless steel unit with titanium jaws, complete with PTFE cutting block. 1 reusable unit.
Corneal Marker - 8 blades, 2 sizes available: 7.0mm, 8.0mm. 1 piece per box
...ntrol you've come to demand in BD K-3000 microkera...keratome is built upon. , ,The BD K-4000 Micro...e front panel on the new console has been designed...ck., ,The BD K-4000 Microkeratome has been eng...
The 4.5/5.0 mm Cannulated Screw System is part of a series of modular systems developed by DePuy ACE for cannulated screws ranging from 3.5mm to 8.0mm. Complete with instruments, disposables and scre
Medicine Products: